Long Term Administration of Inhaled Dry Powder Mannitol In Cystic Fibrosis - A Safety and Efficacy Study

PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Cystic Fibrosis
Interventions
DRUG

Mannitol

400mg BD for 6 months followed by a 6 month open label period

DRUG

placebo

placebo BD for 6 months

Trial Locations (29)

2145

Childrens Hospital at Westmead, Sydney

3052

Royal Childrens Hospital, Melbourne

4029

Royal Brisbane Children's Hospital, Brisbane

4032

The Prince Charles Hospital, Brisbane

Unknown

Sydney Childrens Hospital, Sydney

Royal Adelaide Hospital, Adelaide

Beaumont Hospital, Dublin

National Children's Hospital, Dublin

Our Lady's Hospital for Sick Children, Dublin

St Vincent's University Hospital, Dublin

Alder Hey Children's Hospital, West Derby

Birmingham Children's Hospital, Birmingham

Birmingham Heartlands Hospital, Birmingham

Bristol Royal Hospital for Children, Bristol

Bristol Royal Infirmary, Bristol

Addenbrooke's Hospital, Cambridge

Papworth Hospital, Cambridge

Seacroft Hospital, Leeds

Nottingham City Hospital, Nottingham

Northern General Hospital, Sheffield

Sheffield Children's Hospital, Sheffield

Southampton General Hospital, Southampton

BT9 7AB

Belfast City Hospital, Belfast

CF14 4XW

Children's Hospital for Wales, Cardiff

CF64 2XX

Llandough Hospital, Cardiff

L14 3PE

Cardiothoracic Centre, Liverpool

E2 9JX

The London Chest Hospital, London

NE7 7DN

Freeman Hospital, Newcastle

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Syntara

INDUSTRY